J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors - Unaudited Financial Results For The Quarter Ended June 30, 2022
Outcome of meeting of Board of Directors - Unaudited Financial Results for the quarter ended June 30, 2022 J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investors/analysts call with management J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Fixes Record Date For Final Dividend
Intimation of Record Date pursuant to Regulation 42 of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Reg. 34 (1) Annual Report.
Annual Report for the year 2021-22 J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Notice Of Annual General Meeting
Disclosure under regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended On June 30, 2022
J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2022 ,inter alia, to consider and approve unaudited financial results for the quarter ended on June 30, 2022 J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Sandeep PhadnisDesignation :- Company Secretary and Compliance Officer J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018